Quantitative CT Biomarkers to Predict Metastatic RCC Response to Anti-Angiogenic Therapy

Grant

Date/time Interval

  • September 15, 2019 - September 14, 2021
  • Total Award Amount

  • 445500.00
  • Direct Costs

  • 300000.00
  • Sponsor Award Id

  • W81XWH1910764
  • Contributor

  • Andrew Smith M.D., Ph.D.   Principal Investigator  
  • Desiree Morgan M.D.   Investigator  
  • John Thomas   Investigator  
  • Samuel Galgano   Investigator  
  • Yufeng Li Ph.D.   Investigator